HC Wainwright & Co. Reiterates Neutral on CareDx
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Neutral rating on CareDx (NASDAQ:CDNA).
May 31, 2024 | 5:52 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. analyst Yi Chen has reiterated a Neutral rating on CareDx. This suggests that the analyst does not foresee significant short-term changes in the stock's performance.
The reiteration of a Neutral rating indicates that the analyst does not expect significant positive or negative movement in the stock price in the short term. This is a signal for investors to hold their current positions.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100